NDC00186-0642-01 — DOPAMINE HYDROCHLORIDE INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00186-0642-01: DOPAMINE HYDROCHLORIDE INJECTION.

DOPAMINE HYDROCHLORIDE INJECTION. Key specifications include administration: INTRAVENOUS, special_features: NONPYROGENIC; TO BE DILUTED FOR IV USE, features_provided: STERILE, primary_container_type: SYRINGE-NEEDLE UNIT, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-159-6865, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00186-0642-01

NSN: 6505-01-159-6865
FSC: 6505 — Drugs and Biologicals
CAGE: 04473 — ASTRA PHARMACEUTICALS LP (USA)

SPECIFICATIONS

administration	INTRAVENOUS
special_features	NONPYROGENIC; TO BE DILUTED FOR IV USE
features_provided	STERILE
primary_container_type	SYRINGE-NEEDLE UNIT
pharmaceutical_vehicle_type	AQUEOUS
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	5.000 MILLILITERS
active_medicament_medicinal_strength	160.0 MILLIGRAMS DOPAMINE HYDROCHLORIDE ACTIVE INGREDIENT PER ML
NSN	6505-01-159-6865

COMPONENT DIAGRAM

KEY FEATURES

•

ADMINISTRATION: INTRAVENOUS

•

PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

FEATURES PROVIDED: STERILE

•

PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT

•

PHARMACEUTICAL VEHICLE TYPE: AQUEOUS

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 160.0 MILLIGRAMS DOPAMINE HYDROCHLORIDE ACTIVE INGREDIENT PER ML

TECHNICAL CHARACTERISTICS

ADMINISTRATION	INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY	5.000 MILLILITERS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
FEATURES PROVIDED	STERILE
PRIMARY CONTAINER TYPE	SYRINGE-NEEDLE UNIT
SPECIAL FEATURES	NONPYROGENIC; TO BE DILUTED FOR IV USE
PHARMACEUTICAL VEHICLE TYPE	AQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH	160.0 MILLIGRAMS DOPAMINE HYDROCHLORIDE ACTIVE INGREDIENT PER ML

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 2

INTROPIN RAP-ADDReference document

Same NSN cross-reference

Reference document — Secondary reference

NDC00097-0047-07Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC00186-0642-01?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00186-0642-01?

NDC00186-0642-01 is a DOPAMINE HYDROCHLORIDE INJECTION.

What parts can replace NDC00186-0642-01?

There are 2 known substitutes for NDC00186-0642-01: INTROPIN RAP-ADD, NDC00097-0047-07. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00186-0642-01?

NDC00186-0642-01 is cataloged in the U.S. Government catalog under NSN 6505-01-159-6865. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00186-0642-01 — DOPAMINE HYDROCHLORIDE INJECTION

Request a Quote — NDC00186-0642-01